a novel 21-aminosteroid , 21- [ 4- ( 2,6-di-1-pyrrolidinyl-4-pyrimidinyl ) -1- piperazinyl ] -16 alpha-methylpregna-1,4,9 ( 11 ) -triene-3,20-dione monomethanesulfonate ( i ) , is under development for the treatment of central nervous system injury in humans .
C3538902
di
C0086418
humans